The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kow, DS Ramachandram… - Immunopharmacology …, 2022 - Taylor & Francis
Aim Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
[HTML][HTML] The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis …
CS Kow, DS Ramachandram… - Immunopharmacology …, 2021 - ncbi.nlm.nih.gov
Aim Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kow, DS Ramachandram… - Immunopharmacology and …, 2021 - europepmc.org
Aim Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kow, DS Ramachandram… - Immunopharmacology …, 2022 - research.monash.edu
Aim: Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kow, DS Ramachandram… - Immunopharmacology …, 2022 - pubmed.ncbi.nlm.nih.gov
Aim Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kow, DS Ramachandram, SS Hasan - 2022 - cabidigitallibrary.org
Aim: Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kow, DS Ramachandram… - Immunopharmacology and …, 2022 - pure.hud.ac.uk
Aim: Several randomized trials have evaluated the effect of neutralizing monoclonal
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
antibodies on the risk of hospital admission and risk of mortality in patients with COVID-19 …
[PDF][PDF] The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of …
CS Kowa, DS Ramachandramb, SS Hasanc - pure.hud.ac.uk
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in
patients with COVID-19: a systemat Page 1 The use of neutralizing monoclonal antibodies and …
patients with COVID-19: a systemat Page 1 The use of neutralizing monoclonal antibodies and …